https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iib-study-of-bp1002-a-liposomal-bcl-2-antisense-oligodeoxynucleotide-in-patients-with-refractoryrelapsed-acute-myeloid-leukemia-aml
A Phase I/Ib Study of BP1002 (a Liposomal Bcl-2 Antisense Oligodeoxynucleotide) in Patients with...
This clinical trial is for men and women with acute myeloid leukemia (AML) whose cancer has been treated before and has either recurred or did not respond to...